Dabiduo Tablet 10/5 mg (Ezetimibe, Rosuvastatin Calcium)

Adult dose

This medication is taken once daily, regardless of meals. For primary hypercholesterolemia, an initial dosage of 10/5 mg once a day is recommended. For patients requiring greater LDL-cholesterol reduction, the dosage can be adjusted. Blood lipid levels should be checked after an interval of more than 4 weeks after starting treatment or adjusting the dosage, and the dosage can be adjusted accordingly. The maximum dosage can be increased up to 10/20 mg daily.

This medication may cause serious muscle problems, so if sudden muscle pain or weakness occurs, the doctor should be informed immediately. There is a risk of renal function deterioration due to muscle damage, so caution is needed if there are renal diseases or risk factors. Patients who are allergic to the ingredients in this medication, patients with severe liver disease, patients with muscle disorders, severely impaired renal function patients, and women who are pregnant or nursing should not use this medication. Patients, especially those at high risk for myopathy, should have blood tests to check for muscle damage indicators before starting treatment and undergo regular tests during treatment. Because liver function abnormalities may occur, liver function test results should be periodically checked, and if liver damage is suspected, medication should be stopped immediately. This medication should be used cautiously in individuals with a history of excessive alcohol use or liver disease. Interactions may occur when used with other medications, so any medications currently being taken must be reported to the doctor or pharmacist. Women of childbearing potential should use proper contraceptive methods while taking this medication, and medical treatment should be discontinued immediately upon confirmation of pregnancy. Symptoms such as dizziness may occur, so caution is needed when driving or operating machinery. The safety of this medication has not been established in children and is not recommended. There is no specific antidote for overdose; therefore, treatment should be provided based on symptoms, and monitoring of liver function and muscle damage indicators is necessary. When storing this medication, keep it out of reach of children and do not transfer it to another container.

Serious side effects

Urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, peeling skin, oral/ocular mucosal pain, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, jaundice with skin or eye yellowing, extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion of consciousness, visual disturbances, paralysis, urine

Mild side effects

• Headache
• nasopharyngitis
• arthralgia
• dizziness
• upper respiratory tract infection
• myalgia
• fatigue
• weakness
• itching
• rash

This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. The storage temperature should ideally be maintained between 1°C and 30°C at room temperature.

Appearance

White to nearly white round film-coated tablet

Package unit

30 tablets/bottle